Patents by Inventor Sheri Barrack

Sheri Barrack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEGYLATED C-PEPTIDE
    Publication number: 20150087586
    Abstract: The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise conjugated C-peptide derivatives which exhibit superior pharmacokinetic and biological activity in vivo.
    Type: Application
    Filed: March 25, 2013
    Publication date: March 26, 2015
    Inventors: Sheri Barrack, James Callaway, Michelle Mazzoni
  • Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide
    Patent number: 8962553
    Abstract: The present invention relates to PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit improved pharmacokinetic and biological activity in vivo.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: February 24, 2015
    Assignee: Cebix AB
    Inventors: John Wahren, Sheri Barrack, James Callaway, Michelle Mazzoni, Howard Foyt, Mark Daniels
  • Pegylated C-peptide
    Patent number: 8927488
    Abstract: The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit superior pharmacokinetic and biological activity in vivo.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: January 6, 2015
    Assignee: Cebix, Inc.
    Inventors: Sheri Barrack, James Callaway, Michelle Mazzoni
  • Pegylated C-peptide
    Patent number: 8691755
    Abstract: The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit superior pharmacokinetic and biological activity in vivo.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: April 8, 2014
    Assignee: Cebix AB
    Inventors: Sheri Barrack, James Callaway, Michelle Mazzoni
  • EXTENDED RECOMBINANT POLYPEPTIDE-MODIFIED C-PEPTIDE
    Publication number: 20130316946
    Abstract: The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise modified C-peptide derivatives which exhibit superior pharmacokinetic and biological activity in vivo.
    Type: Application
    Filed: May 24, 2013
    Publication date: November 28, 2013
    Applicant: Cebix, Inc.
    Inventor: Sheri BARRACK
  • PEGYLATED C-PEPTIDE
    Publication number: 20120220542
    Abstract: The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit superior pharmacokinetic and biological activity in vivo.
    Type: Application
    Filed: May 4, 2012
    Publication date: August 30, 2012
    Applicant: CEBIX, INC.
    Inventors: Sheri Barrack, James Callaway, Michelle Mazzoni
  • PEGYLATED C-PEPTIDE
    Publication number: 20120178676
    Abstract: The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit superior pharmacokinetic and biological activity in vivo.
    Type: Application
    Filed: May 17, 2011
    Publication date: July 12, 2012
    Applicant: CEBIX, INC.
    Inventors: Sheri Barrack, James Callaway, Michelle Mazzoni